Igor Astarloa reached the summit of professional cycling in 2003, winning the Flèche Wallonne and then taking the elite road-race world title in Hamilton, Canada. His victory later became part of a troubling blood-profile narrative: according to the account, his samples had attracted scrutiny in the aftermath of that championship and again before the events of 2008–09, although no infraction was formally imposed at the time. The controversy intensified in May 2008, when Team Milram terminated his contract after reports that he had shown “irregular blood values.” Astarloa moved to the Amica Chips-Knauf team, but that squad folded in May 2009, leaving him without a stable professional home just as cycling’s anti-doping system was becoming more sophisticated. In June 2009, he became one of the first five riders identified as falling foul of the Union Cycliste Internationale’s newly introduced biological passport system, which tracks an athlete’s blood markers over time rather than relying only on a single positive test. The Spanish Cycling Federation’s Disciplinary Commission eventually imposed a two-year suspension and a €35,000 fine, announced by the UCI on December 1, 2010. Unable to secure another contract, Astarloa retired in January 2010; the case illustrated how suspicious longitudinal blood data could end a career even when an earlier world championship had never been stripped and no conventional infraction had previously been punished.
Follow the sources
Status and citations are supplied by the archive. AI concept art is an interpretation, not historical evidence.